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Abstract
Satellite cells are myogenic stem cells responsible for the post-natal growth, repair and
maintenance of skeletal muscle. This review focuses on the basic biology of the satellite cell with
emphasis on its role in muscle repair and parallels between embryonic myogenesis and muscle
regeneration. Recent advances have altered the long-standing view of the satellite cell as a
committed myogenic stem cell derived directly from the fetal myoblast. The experimental basis for
this evolving perspective will be highlighted as will the relationship between the satellite cell and
other newly discovered muscle stem cell populations. Finally, advances and prospects for cell-based
therapies for muscular dystrophies will be addressed.
Introduction
Skeletal muscle is subject to constant injury resulting from
weight bearing, exercise, and trauma, thereby requiring an
ever-available, renewable source of cells for muscle repair
and regeneration. Since its identification, the satellite cell
has been a popular candidate for the adult skeletal muscle
"stem cell" [1]. Residing dormant beneath the basal lam-
ina of mature skeletal muscle fibers, this cell is ideally
located for timely repair of degenerating muscle fibers.
Additionally, these quiescent cells are activated to prolif-
erate upon muscle injury, a necessary step towards gener-
ating sufficient numbers of myoblasts for muscle
differentiation and myotube formation. However, the
identification of multiple stem cell populations resident
in skeletal muscle has added further complexity to under-
standing the process of muscle regeneration. In this mini-
review, we will briefly examine the molecular and mor-
phological characteristics of the satellite cell, its role in
muscle regeneration, and discuss outstanding questions
regarding its origin, developmental potential, and uses in
myoblast therapy.
Muscle Regeneration Parallels Myogenesis in the 
Embryo
Although the developmental origin of satellite cells
remains unknown, in vertebrates, the majority of skeletal
muscle progenitors arise in the somites. Somites are tran-
sient epithelial spheres that pinch off of the paraxial mes-
oderm lining both sides of the neural tube. Myogenic
precursors are first identified in the dermomyotome, an
epithelial layer located in the dorsal compartment of the
somite. These precursors are characterized by their expres-
sion of the paired box transcription factors Pax-3 and Pax-
7; in response to signals such as Wnts and Sonic hedgehog
from surrounding embryonic structures, the myogenic
determination genes Myf-5 and MyoD are activated [3].
Coinciding with the down-regulation of Pax gene expres-
sion, muscle precursor cells committed to the skeletal
muscle lineage (myoblasts) translocate to the subjacent
myotome, where the muscle regulatory factors Myogenin
and MRF4 direct differentiation and fusion into multi-
nucleated myofibers.Satellite cells are first apparent
towards the end of embryogenesis, and function as a pri-
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mary source for the myogenic cells required for post-natal
muscle growth [2]. 
In adult muscles, dormant, Pax-7-expressing satellite cells
reside between the plasmalemma and basal lamina at fre-
quencies that vary with age, muscle fiber type, and species
[4]. The activation of satellite cells in vivo can be induced
by muscle fiber injury brought on by acute injury [5-7],
exercise [8-10], and denervation [11]. Upon injury, satel-
lite cells are stimulated to re-enter the cell cycle to generate
a pool of proliferating myogenic precursors analogous to
the embryonic myoblasts, while the inflammatory
response mounted by the immune system clears affected
myofibers [2]. Recently, certain Wnt-family members
were found to be up-regulated in muscle following injury,
suggesting a parallel to myogenic signaling pathways in
the embryo [12]. Additionally, up-regulation of Myf-5 and
MyoD occurs at the injury site in proliferating satellite cells
indicating cell commitment [13-17]. Pax-7  expression
declines with the up-regulation of MRF-4 and Myogenin,
and differentiated myocytes fuse to new and existing fib-
ers as part of the repair process. One of the hallmarks of
regenerating myofibers is the centrally located position of
the myonuclei; upon maturing, muscle fiber nuclei are
located along the cell periphery [4]. Notably, repeated
cycles of injury and regeneration do not appear to deplete
satellite cell numbers, suggesting that these cells have the
ability to self-renew [2].
Fiber- and Age-related Variation in Satellite Cell 
Frequency
Satellite cells were initially identified in frog leg muscles
by electron microscopy [1], and subsequently have been
identified in all higher vertebrates. In humans and mice,
these quiescent [18], non-fibrillar, mononuclear cells are
most plentiful at birth (estimated at 32% of sublaminar
nuclei) [19]. The frequency declines post-natally, stabiliz-
ing to between 1 to 5% of skeletal muscle nuclei in adult
mice [2]. Satellite cell frequency varies in different mus-
cles, likely as a function of variation in fiber type compo-
sition (i.e. slow oxidative, fast oxidative, or fast glycolytic
fibers). For example, the mouse soleus muscle, which is
predominantly made up of slow oxidative fibers, has a
higher number of satellite cells than the extensor digito-
rum longus (EDL) muscle, which primarily contains fast
glycolytic fibers. Additionally, the absolute numbers of
satellite cells increases in the soleus but not the EDL
between 1 and 12 months of age, although the proportion
of satellite cells decreases in both muscle types with
increasing age [20]. In humans, the proportion of satellite
cells in skeletal muscles also decreases with age, which
may explain the decreased efficiency of muscle regenera-
tion in older subjects [21]. Satellite cells from aged muscle
also display reduced proliferative and fusion capacity, as
well as a tendency to accumulate fat, all of which likely
contribute to deteriorating regeneration capability
[22,23]. That endurance training can offset the decline in
satellite cell number with age suggests that poorer regen-
eration is not simply a result of limited replicative poten-
tial of older satellite cells [24].
Molecular Basis of Satellite Cell Activation and 
Differentiation
Several signals and growth factors have been implicated in
promotion of satellite cell activation and proliferation
(Figure 1). For example, the Notch signaling pathway,
which is activated upon muscle injury, regulates satellite
cell transition from quiescence to proliferation in single
fiber cultures, thereby expanding the myoblast popula-
tion in injured muscle [25]. Basic fibroblast growth factor
(bFGF) stimulates satellite cell proliferation while inhibit-
ing differentiation [2]. bFGF also promotes muscle regen-
eration in mdx mice [26], which undergo repeated cycles
of degeneration and regeneration resulting from a muta-
tion in the dystrophin gene; in humans, deficiency of dys-
trophin causes Duchenne muscular dystrophy [27,28]. In
addition to expressing all known FGF receptors [29,30],
satellite cells also express the tyrosine kinase receptor c-
met [16,31]. The c-met ligand, hepatocyte growth factor/
scatter factor (HGF/SF), is also a known activator of satel-
lite cells [29,32].
Targeted deletion of the gene encoding the Forkhead/
winged helix transcription factor Foxk1 [previously
known as myocyte nuclear factor (MNF)], which is
expressed in quiescent satellite cells, causes a severely
runted phenotype, and cardiotoxin-induced muscle
regeneration is delayed and accompanied by prominent
accumulation of adipose cells, suggesting a defect in skel-
etal muscle commitment [33]. Interestingly, the myopa-
thy associated with the Foxk1 mutant is rescued when bred
into a p21-null background. p21 is up-regulated in Foxk1-
null muscles, and while mice lacking this cyclin-depend-
ent kinase inhibitor show a defect in satellite cell differen-
tiation, double mutants exhibit normal muscle growth
and regeneration, suggesting that p21 is a downstream tar-
get of Foxk1 [34,35].
The muscle determination gene MyoD is also required for
normal muscle regeneration [36]. Regenerating muscles
in  MyoD-null animals accumulate high numbers of
mononuclear cells and have few differentiated myotubes;
this phenotype is exacerbated in an mdx background,
with  MyoD-/-; mdx muscles exhibiting severely reduced
cross-sectional area and mass. MyoD-null animals exhibit
increased numbers of satellite cells, suggesting that the
cells fail to progress through the differentiation program
and instead participate in self-renewal [36]. The abnormal
proliferation observed with MyoD-null adult myoblasts
and failure to up-regulate the muscle differentiation fac-Reproductive Biology and Endocrinology 2003, 1 http://www.rbej.com/content/1/1/101
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Model for the development, activation, and maintenance of the satellite cell Figure 1
Model for the development, activation, and maintenance of the satellite cell. Upon skeletal muscle injury, quiescent satellite 
cells expressing Pax-7 and Foxk1 are activated to proliferate, up-regulating the myogenic determination factors, MyoD and Myf-
5 [13-17], the myoblast marker desmin [16,79], and Wnts 5a and 5b [12]. Satellite cell activation is regulated by the Notch sign-
aling pathway [25], and proliferation is stimulated by a number of growth factors, including basic FGF, insulin-like growth fac-
tor-1, and HGF/SF [26,32,80]. Transition from proliferation to differentiation, which is accompanied by the down-regulation of 
Pax-7 [57] and up-regulation of Myogenin and MRF-4 [13,14,16], is dependent on both MyoD [36] and the Foxk1 pathway 
[33,34]. Candidate satellite cell progenitors, which must activate Pax-7 for satellite cell development [57], include embryonic 
myoblast precursors, fetal myoblasts, and vessel-associated mesoangioblasts, the latter of which exhibits strong myogenic 
potential [60-62]. Additionally, bone marrow-derived (BMD) stem cells can contribute directly to quiescent satellite cells and 
regenerating muscle fibers following injury [54,65,68], and muscle SP cells have been used with some success in myoblast trans-
plantation experiments into dystrophic muscle [53,54]. Importantly, members of the Wnt family of secreted glycoproteins can 
convert SP cells favoring the hematopoietic fate into highly myogenic cells [12].
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tors MRF-4 or Myogenin under differentiation conditions
support this hypothesis [37,38]. In addition, MyoD-null
satellite cells express increased levels of Myf-5 [37,38]. In
embryos lacking MyoD, myogenesis is dependent on Myf-
5 and vice versa: while single mutant embryos have nor-
mal muscles at birth, MyoD-/-;  Myf-5-/- double mutant
embryos fail to develop myoblasts or myotubes [39-41].
Given the defects in muscle regeneration observed in
adult  MyoD  mutants, it is evident that the functional
redundancy between MyoD and Myf-5 that ultimately res-
cues embryonic muscle development is not sufficient to
rescue myogenesis in injured muscle.
Muscle Stem Cell Plasticity
Interestingly, while traditionally thought to be committed
to the skeletal muscle fate, it is now evident that muscle
stem cells, including satellite cells, are multipotent. For
example, bone morphogenetic protein (BMP) treatment
activates osteogenic markers while down-regulating MyoD
in C2C12 myoblasts, an immortalized cell line derived
from mouse limb muscle [42,43]. Additionally, treatment
with thiazolidinediones and fatty acids converts C2C12
cells to the adipogenic cell fate [44]. Primary myoblast
cultures from adult muscles respond similarly to C2C12
cells in the presence of strong osteogenic and adipogenic
inducers; interestingly, satellite cells derived from intact
single fiber cultures (and thought to be more representa-
tive of true myogenic stem cells) spontaneously form adi-
pocytes and osteocytes when cultured on Matrigel, a
soluble basement membrane matrix lacking strong osteo-
genic or adipogenic signals [45]. The finding that undiffer-
entiated cells in adult myoblast cultures co-express MyoD,
Runx2, and PPARγ, key regulators for myogenesis, osteo-
genesis, and adipogenesis, respectively, supports the
hypothesis that satellite cells have a multipotential predis-
position [46].
The plasticity of muscle stem cells has also been demon-
strated using ex vivo approaches. Muscle stem cells iso-
lated via serial preplating enrich for a population of cells
which, in addition to contributing to regenerating
myofibers when injected directly into dystrophic muscle,
are detected in differentiated vascular and nerve cells
[47,48]. Furthermore, these cells, which express the
myoblast markers desmin and MyoD, are sufficient to com-
pletely heal skull defects in vivo when engineered to
express BMP [49]. These muscle-derived stem cells are also
capable of reconstituting bone marrow in lethally irradi-
ated mice [50].
Another muscle-based stem cell with hematopoietic
potential is the muscle side population (SP) cell, which
can be isolated based on its specific exclusion of the vital
dye Hoechst 33342 [51]. Initially sorted from bone mar-
row derived (BMD) stem cells by FACS analysis and
observed to possess the majority of hematopoietic stem
cell activity in bone marrow [52], SP cells have since been
identified in a variety of tissues, including skeletal muscle,
brain, heart, spleen, kidney and lung, although they are
notably absent in peripheral blood [53]. It is important to
note that the relationship between these different SP pop-
ulations, and whether or not they derive from a common
precursor, remains to be determined. Muscle SP cells
reconstitute bone marrow in lethally irradiated mdx mice,
although less efficiently than BMD SP cells. Interestingly,
donor-derived nuclei also appear in regenerating muscle
fibers after bone marrow reconstitution, indicating a con-
tribution by the hematopoietic system in muscle repair
[51,54]. The heterogeneity of muscle stem cells is under-
scored by the observation that SP cells within normal,
uninjured skeletal muscle can be distinguished as positive
for the hematopoietic marker CD45 (and poorly myo-
genic) or CD45-negative (a population that readily differ-
entiates along the myogenic pathway) [55]. The CD45-
positive subpopulation of cells has also been shown to
contribute to neo-vascularization in regenerating muscle,
whereas the CD45-negative population does not [56].
Interestingly, Wnts 5a, 5b, 7a and 7b, which are up-regu-
lated in myoblasts and myofibers of regenerating muscle,
convert the normally resistant CD45-positive muscle SP
fraction to the myogenic program; this property to induce
a switch in fate could contribute to the recruitment of
much-needed progenitors upon injury [12].
The Developmental Origin of Satellite Cells
A recent study of the Pax-7-null mouse revealed that this
paired box transcription factor is essential for satellite cell
formation. In addition to exhibiting severe muscle defi-
ciency at birth and premature lethality, Pax-7 mutants are
completely devoid of satellite cells [57]. However, while
this observation demonstrates the requirement for Pax-7
in satellite cell formation, it remains to be seen whether
the satellite cell arises from a pre-determined myoblast in
the dermomyotome, a fetal myoblast, or from a non-som-
itic progenitor. Satellite cells may originate from specified
Pax-7-positive cells prior to the activation of Myf-5 and
MyoD, and thus represent a true precursor to the myogenic
lineage. Alternatively, satellite cells may arise from deter-
mined myoblasts which, instead of differentiating, con-
tinue to proliferate until withdrawing from the cell cycle
and taking up residence beneath the basal lamina of
myofibers. While relatively little is known about the cis
regulation of the Pax-7 gene, the extensive characteriza-
tion of Myf-5 and MyoD regulatory elements [3,58] can be
used to determine if satellite cells originate from a Myf-5
or MyoD-positive population by in vivo cell tracing. Inter-
estingly, while Pax-7-null animals lack satellite cells, the
muscle SP population remains intact, although exhibiting
increased hematopoietic potential; Pax-7 may direct spec-
ification of pluripotent SP cells to satellite cells [57,59].Reproductive Biology and Endocrinology 2003, 1 http://www.rbej.com/content/1/1/101
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The observation that various non-muscle stem cells can
participate in skeletal muscle regeneration has expanded
the candidate pool for the satellite cell precursor. For
example, myogenic potential has been demonstrated in
vivo by mesoangioblasts, which are vessel-associated stem
cells [60-62], neural stem cells [63], and, as mentioned
previously, bone marrow cells [64,65].
Bone marrow cells have long been known to have myo-
genic potential [66,67]. Direct injection of β-galactosi-
dase-positive bone marrow cells into cardiotoxin-injured
muscle gives rise to labeled myofibers, although at a lower
frequency than injected satellite cells [64]. Interestingly,
bone marrow cells contribute directly to regenerating
myofibers in lethally irradiated mdx bone marrow trans-
plant recipients [68]. Surprisingly, in the absence of myo-
genic induction, a subset of bone marrow cells in mdx
mice are positive for both early and late myogenic markers
including Pax3, MyoD, and myosin heavy chain, suggest-
ing that muscle commitment and differentiation are
underway [69]. Also intriguing is the finding that GFP-
labeled BMD cells take up residence beneath the basal
lamina of skeletal muscle fibers in irradiated transplant
recipients following injury (in this case, an exercise
model), with subsequent injury provoking an increased
contribution of BMD cells to regenerated muscle fibers
[65]. This suggests that satellite cells are maintained in
regenerating fibers through self-renewal as well as replen-
ishment from the bone marrow. It remains to be seen
what proportion of satellite cells arise anew with each
round of injury, and whether multiple rounds of injury
results in a complete turnover of host satellite cells with
donor bone marrow cells.
Advances in Muscle Stem Cell Therapy
The use of muscle stem cells for therapeutic purposes
holds much promise for treatment of diseases affecting
skeletal muscle, including muscular dystrophy [70]. Dys-
trophic muscles that receive myoblast transplants exhibit
some dystrophin-positive myofibers, and persistence of
donor fibers in regenerated muscles is observed [71-73].
However, certain roadblocks hinder the efficacy of this
therapy, including the limited migration of donor cells
into dystrophic muscle and problems with poor donor
cell survival and inefficient myogenic contribution.
Advances have been made in identifying chemotactic fac-
tors and cell surface molecules that enhance the migration
of transplanted cells [74-76]. In addition, careful selection
of donor cells has been shown to enhance efficiency of
rescue and cell survival in transplant hosts. In particular,
Huard and colleagues have found that their serial pre-
plated muscle stem cell cultures display enhanced prolif-
erative capabilities and readily contribute to regenerating
muscle while failing to trigger a strong immune response
[47,77]. Furthermore, CD45-positive muscle SP cells also
contribute to regenerating muscle with high efficiency
[54,59].
The use of bone marrow transplants for treating muscular
dystrophy has been contemplated as an alternative ther-
apy to myoblast injection and, as mentioned previously,
BMD cells do contribute to regenerating muscle. In fact,
bone marrow derived nuclei have been identified in mus-
cle biopsies from a 15-year-old patient who received a
bone marrow transplant at age 1, and was diagnosed with
a mild case of Duchenne muscular dystrophy at age 12
[78]. While this demonstrates the longevity of trans-
planted cells in muscle, it remains to be seen whether the
contribution of these cells to regenerating muscle is
responsible for the mild form of the patient's disease.
Intriguingly, intra-arterial injection of wild-type mesoan-
gioblasts into mice suffering from limb girdle muscle dys-
trophy results in complete functional recovery of all
affected muscles [62]. This presents a promising solution
to difficulties encountered with myoblast transplantation
therapy, and makes all muscles accessible for treatment.
This is especially important for the treatment of essential
muscles such as the diaphragm, impairment of which
results in severe respiratory problems.
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